Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
Fabrice CamouNahéma IssaMojgan HessamfarOlivier GuissetGaëlle MourissouxStéphane PedeboscqAimée MinotFabrice BonnetPublished in: Journal of clinical medicine (2022)
In critically ill COVID-19 patients, the addition of tocilizumab to dexamethasone was not associated with an increased risk of superinfection.